Mr Edick is currently CEO of Durata Therapeutics Inc, and brings to Circassia significant commercial experience having held a number of senior international roles in the pharmaceutical industry
Circassia Appoints Paul R Edick to its Board of Directors
Mr Edick is currently CEO of Durata Therapeutics Inc, and brings to Circassia significant commercial experience having held a number of senior international roles in the pharmaceutical industry
Tags
Related posts
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
